These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2443479)

  • 21. [Alpha-fetoprotein as a tumor marker].
    Yachi A; Suga M
    Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma].
    Matsushima A; Enomoto M; Yokoo Y; Arai M; Kobayashi T; Okuno F; Hirano Y; Sujita K; Eto S; Takagi T
    Rinsho Byori; 1989 Jun; 37(6):683-6. PubMed ID: 2477568
    [No Abstract]   [Full Text] [Related]  

  • 23. In the new area of noninvasive markers of hepatocellular carcinoma.
    Paradis V; Bedossa P
    J Hepatol; 2007 Jan; 46(1):9-11. PubMed ID: 17112623
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum alpha-fetoprotein and hepatocellular carcinoma size.
    Piantino P; Fusaro A; Daziano E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412
    [No Abstract]   [Full Text] [Related]  

  • 25. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
    Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
    Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
    Chan SL; Chan AT; Yeo W
    Future Oncol; 2009 Aug; 5(6):889-99. PubMed ID: 19663737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay of serum A1-antitrypsin activity for the diagnosis of primary hepato-cellular carcinoma.
    Xu SK; Guan SF; Wang PL; Chen FH; Yu EX; Xu HQ
    Chin Med J (Engl); 1983 Aug; 96(8):607-10. PubMed ID: 6196162
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tumor markers for hepatocellular carcinoma].
    Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
    Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
    Yao DF; Dong ZZ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis.
    Correale M; Giannuzzi V; Iacovazzi PA; Valenza MA; Lanzillotta S; Abbate I; Quaranta M; Caruso ML; Elba S; Manghisi OG
    Anticancer Res; 1999; 19(4C):3469-72. PubMed ID: 10629637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].
    Nakamura K; Makino I
    Ryoikibetsu Shokogun Shirizu; 1995; (7):265-8. PubMed ID: 8749467
    [No Abstract]   [Full Text] [Related]  

  • 36. [Discriminant function based on serum analyte for diagnosis of primary hepatic cancer].
    Yi B; Luo JQ; Tang Y; Huang YD
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):373-5. PubMed ID: 12206007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of AFPmRNA in blood of patients with recurrent hepatocellular carcinoma.
    Liu Y; Zhang BH; Qian GX; Chen H; Wu MC
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):274-7. PubMed ID: 14599983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative value of tomoechography, laparoscopy, directed liver biopsy, selective arteriography and determination of alpha-fetoproteins in the diagnosis of hepatocarcinoma].
    Pérez-Jiménez F; Cano JM; Segura JM; Hita J; Muró J; Ortiz Vázquez J
    Rev Clin Esp; 1975 Jul; 138(2):113-23. PubMed ID: 52170
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
    Gonzalez SA; Jacobson IM
    Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.